Production & Manufacturing
Production & Manufacturing
Advanced Therapies Manufacturing Supporting Next-Generation Drug Development
The pharmaceutical sector is entering a new era characterized by the rise of cell and gene therapies, which offer the potential to treat or even cure diseases that were previously managed with lifelong medication. These advanced therapies involve the...
Industry Reports
APAC Drug Industry 2026: From Manufacturing Hub to Innovation Powerhouse
For years, APAC was mainly known for producing medicines on a scale.
That picture is changing quickly.
In 2026, the region is becoming a place where drugs are discovered, developed, tested, manufactured and increasingly commercialized. Asia now accounts for around 43%...
Production & Manufacturing
Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs
As pharmaceutical analytical workflows grow more demanding, labs are under increasing pressure to balance trace-level accuracy, validation requirements, documentation, and faster development timelines.
By Brian Alexander, Ph.D., geochemist and Chief Technical Officer at Inorganic Ventures, a manufacturer of inorganic certified...
Business & Industry
Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania
A planned $3.5 billion pharmaceutical manufacturing campus in Upper Macungie Township, Pennsylvania, has advanced through the local development process after the Upper Macungie Planning Commission recommended final subdivision and land development approval on August 19, 2026. Known as Project...
News
Genentech Completes Structural Framework at New NC Manufacturing Facility
Genentech raised the final beam of its new Holly Springs, North Carolina manufacturing facility on August 18, marking the completion of the structural framework for what will become the company's first East Coast manufacturing site in the United States.
The...
Business & Industry
Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351
Japan-based Chugai Pharmaceutical has entered into an exclusive license agreement with British pharmaceutical company GlaxoSmithKline (GSK) for the anti-dengue virus antibody known as AID351, in a move that advances global efforts to combat one of the world's most widespread...
Production & Manufacturing
Bilayer Tablets Supporting Combination Drug Delivery
The pharmaceutical industry has increasingly turned toward fixed-dose combinations to improve patient compliance and therapeutic efficacy. One of the most technologically advanced methods for achieving this is through the production of multilayer solid dosage forms. The utilization of bilayer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














